Risk Management in Early Phase Clinical Trials

Thursday 29th October, 12.30 – 17.00

We are pleased to include below the presentations from this year’s AHPPI Annual Meeting.

Please click the links in or near each speaker’s name to download and open a PDF of the presentation.

12:30	Arrival
13.00	Introduction to the AHPPI Annual Meeting	Prof Keith Wesnes, AHPPI Chair
13.15	Risk Management in a CRO Phase I Unit	Dr John Lambert, PAREXEL
13.50	Risk Management for Early Trials in biologicals	Dr Richard FitzGerald, Royal Liverpool University Hospital
14:20	Tea/Coffee & Networking
14:55	Cardiac Safety – the industry and regulatory perspectives	Dr Boaz Mendzelevski, BioClinica and Dr Krishna Prasad, MHRA
15:35	Use of a novel risk rating system in clinical trials	Dr Brian Leaker, Respiratory Clinical Trials Ltd, Queen Anne Street Medical Centre
16:05	Introduction to EUFEMED & European Training Course in Human Pharmacology	Dr Jörg Täubel, EUFEMED
16:20	Update on the implementation of the new EU Clinical Trial Regulation’s transparency rules for early phase trials	Dr Ulrike Lorch, AHPPI Chair-elect
16:40	AHPPI Updates	Dr Peter Dewland, AHPPI Treasurer, Dr Tim Hardman & Steffan Stringer, AHPPI Committee (slides, speaker notes)
17:00	Closing Remarks followed by drinks reception	Prof Keith Wesnes, AHPPI Chair

We were delighted to be sponsored by BioKinetic Europe and Niche Science & Technology for this year’s programme.